explore -WSS

explore

author：Wikipedia 2025-09-29 13:46:06 - browse：35567

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Adam's Biotech Scorecard: Do Sarepta's exon

hotspot

focus

WSS

Cano Health’s bankruptcy is a warning for Medicare Advantage

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Average age of first period drops to 11.9 years, study shows

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Cano Health’s bankruptcy is a warning for Medicare Advantage

knowledge

explore

hotspot

Virginia high school admissions case could be legal follow

Startling documents reveal new facets of Sacklers' opioid empire

Psychedelics group wrestles with new pharma identity

The Biogen Aduhelm mess could happen again

New air purifier tech could be key to improving indoor air quality

AI used to predict Covid

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD: Venture capital, Gilead, and more M&A

Cancer drug shortages should be causing more outrage

The Biogen Aduhelm mess could happen again

Wikipedia

Prosthetic arm enables patients to feel the objects they grip

AI used to predict Covid

Readout Newsletter: Amgen, Regeneron, BGI Group and more

The CDC's new social media misinformation war

Scientists successfully use ultrasound imaging to map brain activity

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

hotspot

focus

focus

entertainment